Monograph
N05AA01 - Chlorpromazine |
Not porphyrinogenic |
NP |
Rationale
Neuroleptic, frequently used in acute porphyria without any adverse effects. No indications of CYP-inducing effects. Several references state non-porphyrinogenicity. Since long recommended for use during acute porphyric crises.
Chemical description
High-dose neuroleptic phenothiazine with aliphatic side chain. Broad therapeutic spectrum including antipsychotic, sedative and antiemetic effects. Metabolized by CYP 2D6. MFM James, RJ Hift. Porphyrias. Br J Anaesth 2000; 85, 143-53: use (phenothiazines). EPI-list: safe Australian list: safe Merck: safe South African list: use French list: use Kalman, Bonkovsky: safe Moore MR, Hift RJ: Drugs in the acute porphyrias. Cell Mol Biol 43:89, 1997: safe
IPNet drug reports
Uneventful use reported in 14 patients with acute porphyria.
Similar drugs
Tradenames
This list comprises raw data collected from different countries.
In some cases, a more comprehensive list of available drug packages is included.
Consequently, very similar terms may therefore appear multiple times.
Bold names are the searchable terms, while the gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors.
We strive to improve it continuously.
Largactil 
Largactil · Prozin 
Chlorazin · Chlorpromazine · Largactil · Largactil Forte 
Chlorpromazine · Largactil 
Fenactil 
Chlorpromazine · Largactil 
Hlorpromazin
© NAPOS 2025